{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:46:20Z","timestamp":1788345980485,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.tracli.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T19:14:55Z","timestamp":1550862895000},"page":"94-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease"],"prefix":"10.1016","volume":"26","author":[{"given":"R.M.","family":"Fasano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chonat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2019.02.002_bib0145","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1537-2995.1997.37497265337.x","article-title":"Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients\u2019 red cells","volume":"37","author":"King","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.02.002_bib0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MAJ.0b013e3181c70e14","article-title":"Delayed hemolytic transfusion reaction in sickle cell disease","volume":"339","author":"Scheunemann","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.tracli.2019.02.002_bib0155","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajh.24460","article-title":"Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes","volume":"91","author":"Habibi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2019.02.002_bib0160","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.02.002_bib0165","doi-asserted-by":"crossref","first-page":"588","DOI":"10.14423\/SMJ.0000000000000528","article-title":"High percentage of evanescent red cell antibodies in patients with sickle cell disease highlights need for a national antibody database","volume":"109","author":"Williams","year":"2016","journal-title":"South Med J"},{"key":"10.1016\/j.tracli.2019.02.002_bib0170","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MOH.0000000000000462","article-title":"Delayed haemolytic and serologic transfusion reactions: pathophysiology, treatment and prevention","volume":"25","author":"Siddon","year":"2018","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tracli.2019.02.002_bib0175","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/trf.12251","article-title":"Record fragmentation due to transfusion at multiple health care facilities: a risk factor for delayed hemolytic transfusion reactions","volume":"54","author":"Unni","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.02.002_bib0180","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1309\/AJCP47QAAXTOZEKJ","article-title":"A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease","volume":"141","author":"Harm","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.tracli.2019.02.002_bib0185","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1537-2995.2009.02199.x","article-title":"Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death","volume":"49","author":"Chadebech","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.02.002_bib0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1537-2995.2001.41030323.x","article-title":"Hyperhemolytic transfusion reaction in sickle cell disease","volume":"41","author":"Win","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.02.002_bib0195","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1537-2995.2008.01693.x","article-title":"Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review","volume":"48","author":"Win","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.02.002_bib0200","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","article-title":"Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins","volume":"121","author":"Schaer","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.02.002_bib0205","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/bjh.12445","article-title":"Association between plasma free haem and incidence of vaso-occlusive episodes and acute chest syndrome in children with sickle cell disease","volume":"162","author":"Adisa","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2019.02.002_bib0210","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","article-title":"Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients","volume":"127","author":"Dumas","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.02.002_bib0215","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.3324\/haematol.2018.194670","article-title":"Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease","volume":"103","author":"Chonat","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2019.02.002_bib0220","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1182\/blood.V83.3.842.842","article-title":"Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex formation","volume":"83","author":"Test","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.02.002_bib0225","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1537-2995.1997.37497265338.x","article-title":"The sickle cell hemolytic transfusion reaction syndrome","volume":"37","author":"Petz","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.02.002_bib0230","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.hoc.2016.01.011","article-title":"Management of patients with sickle cell disease using transfusion therapy: guidelines and complications","volume":"30","author":"Chou","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.tracli.2019.02.002_bib0235","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/pbc.22327","article-title":"HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease","volume":"54","author":"McPherson","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.tracli.2019.02.002_bib0240","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/blood.V88.8.3216.bloodjournal8883216","article-title":"Alloimmunization to platelets in heavily transfused patients with sickle cell disease","volume":"88","author":"Friedman","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.02.002_bib0245","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra1612789","article-title":"Indications for and adverse effects of red-cell transfusion","volume":"377","author":"Carson","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2019.02.002_bib0250","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/bjh.13339","article-title":"Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience","volume":"169","author":"Vidler","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2019.02.002_bib0255","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.24908","article-title":"Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease","author":"Narbey","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2019.02.002_bib0260","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.02.002_bib0265","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5858\/arpa.2016-0277-SA","article-title":"Genotyping applications for transplantation and transfusion management: the Emory experience","volume":"141","author":"Fasano","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.tracli.2019.02.002_bib0270","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.13123","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"168","author":"Fasano","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2019.02.002_bib0275","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/vox.12217","article-title":"The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease","volume":"108","author":"Noizat-Pirenne","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2019.02.002_bib0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajh.21578","article-title":"Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia","volume":"85","author":"Bachmeyer","year":"2010","journal-title":"Am J Hematol"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782019300308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782019300308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:37:53Z","timestamp":1761129473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782019300308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1246782019300308"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2019.02.002","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}